What You Should Know:
– Heart failure is a critical health issue affecting millions of Americans, and despite decades of research, effective treatment options remain limited. Traditional drug development is a slow, costly, and high-risk…
Continue Reading
What You Should Know:
– ArcaScience, a Paris, France-based AI Healthtech startup, has announced a $7M seed funding round led by The Moon Venture, with participation from Pléiade Venture, Plug&Play Ventures, Bpifrance, and AKKA Technologies….
Continue Reading
What You Should Know:
– Ginkgo Bioworks has announced a new strategic partnership with Inductive Bio and Tangible Scientific to make AI-driven “lab-in-the-loop” drug discovery more accessible to the industry.
– The collaboration combines high-throughput experimental…
Continue Reading
The integration of physics-based digital twins with data-driven artificial intelligence—termed “Big AI”—can advance truly personalised medicine. While digital twins offer individual ‘healthcasts,’ accuracy and interpretability, and AI delivers speed and flexibility, each has limitations….
Continue Reading
What You Should Know:
– Mayo Clinic announced a pivotal step toward integrating AI solutions in the clinical setting with the deployment of NVIDIA DGX SuperPOD with NVIDIA DGX B200 systems.
– The advanced infrastructure provides…
Continue Reading
A £7.5 million global challenge prize has launched to incentivise AI-based approaches to transform drug discovery for the treatment of amyotrophic lateral sclerosis (ALS).
ALS is a form of motor neurone disease (MND) that damages the…
AI drug discovery firm Healx has partnered with SCI Ventures to find and develop therapies for spinal cord injury (SCI).
The collaboration, which was confirmed in February 2025, will see Healx’s AI platform used to…
What You Should Know:
– Certara, a global leader in model-informed drug development, today announced an expanded collaboration with Merck, known as MSD outside of the United States and Canada.
– The strategic agreement will see…
Continue Reading
Allied health professionals (AHPs) should not wait for AI to come to them, write physiotherapists Christopher Efford and Charlie Winward
AI is everywhere. If you’re not using it, you’re probably considering it. It’s the…
Tim Barrow-Williams, Head of Drug Delivery at PA Consulting
Bill Hartman, Pharma and Medtech Design Expert at PA Consulting
Last year, the American Cancer Society predicted that in 2024, the US would reach two million annual…
Continue Reading
